© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
DEAN HAR MD LLC
2080 BRIDGEPORT AVE
April 11, 2019
"Patients with favorable-risk disease who have a DNA repair mutation should be counseled that there is a significantly increased risk of reclassification with AS," writes Stacy Loeb, MD, MSc.